NCT04207736View on ClinicalTrials.gov

The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.

PHASE3CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

December 5, 2019

Primary Completion Date

February 16, 2021

Study Completion Date

February 16, 2021

Conditions
Allergic Conjunctivitis
Interventions
DRUG

Reproxalap Ophthalmic Solution (0.25%)

Reproxalap Ophthalmic Solution (0.25%) dosed in the Environmental Exposure Chamber.

DRUG

Vehicle Ophthalmic Solution

Vehicle Ophthalmic Solution dosed in the Environmental Exposure Chamber.

Trial Locations (1)

Unknown

Cliantha Research, Mississauga

Sponsors
All Listed Sponsors
lead

Aldeyra Therapeutics, Inc.

INDUSTRY